NEW: Flash glucose monitoring – support for people with Type 1 diabetes.
Over the last few months, Doncaster CCG has been reviewing options to support the roll out of flash glucose monitoring for a group of patients with Type 1 diabetes on prescription.
Wearable sensors, the size of a £2 coin is an alternative to finger prick blood testing by relaying glucose levels to a smart phone or e-reader.
Doncaster and Bassetlaw Area Prescribing Committee considered and supported the recommendation to its constituent members that Flash Glucose Sensor (FGS) monitoring be available to patients with Type 1 diabetes who meet the specified criteria on an NHS prescription.
This is in line with the vision set out by NHS England on 14 November to ensure that all eligible patients are able to receive it on prescription from their diabetes specialist and in time from their local GP, this is to help people better manage their blood sugar levels.
Doncaster CCG has now agreed a clinical pathway to roll flash glucose monitoring out to eligible patients living with type 1 Diabetes, aged four and above.
Doncaster CCG will follow the criteria set by NHS England which is as follows:
- Patients already self-monitor their blood glucose more than eight times per day – the average cost of each FGS;
- Those who meet current NICE criteria for insulin pump therapy where a successful trial of FGS may avoid the need for pump therapy, therefore demonstrating a cost saving;
- Those who have recently developed impaired awareness of hypoglycaemia. A trial of FGS can reduce hypoglycaemia and may prevent future need for Continuous Glucose Monitoring (CGM), demonstrating a cost saving;
- Patients who are admitted to hospital more than twice per year as a result of hyperglycaemia episodes. An FGS trial could prevent future admissions;
- Those who require third parties to carry out monitoring and where conventional testing is not possible;
- Children who have significant fear or anxieties of multiple finger prick testing – any child who is diagnosed when aged 16 years or less.
Patients will be able to be referred to specialist Diabetic clinics to be assessed and for a decision to be made with results communicated to their local GP.
Once it has been agreed that the patient is eligible and can effectively use FGS, prescribing responsibilities can transfer to GPs after six months of transferring to the flash glucose system. This will be managed by the specialist diabetes clinic.